Capula Management’s AbbVie ABBV Stock Holding History

Capula Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.39M	Buy	6,392 +4,852	+315%	+$1.08M	0.01%	308
2025 Q4	$352K	Sell	1,540 -3,309	-68%	-$754K	﹤0.01%	454
2025 Q3	$1.12M	Buy	4,849 +3,999	+470%	+$814K	0.01%	342
2025 Q2	$158K	Sell	850 -911	-52%	-$169K	﹤0.01%	420
2025 Q1	$369K	Buy	1,761 +1,240	+238%	+$241K	﹤0.01%	348
2024 Q4	$92.6K	Buy	521 +154	+42%	+$28.3K	﹤0.01%	341
2024 Q3	$72.5K	Buy	367 +184	+101%	+$34.3K	﹤0.01%	459
2024 Q2	$31.4K	Sell	183 -938	-84%	-$155K	﹤0.01%	426
2024 Q1	$204K	Buy	+1,121	New	+$193K	﹤0.01%	404
2023 Q3	–	Sell	-33,604	Closed	-$4.93M	–	501
2023 Q2	$4.53M	Buy	33,604 +31,906	+1,879%	+$4.68M	0.11%	98
2023 Q1	$271K	Buy	+1,698	New	+$260K	﹤0.01%	545
2022 Q4	–	Sell	-44,397	Closed	-$6.81M	–	701
2022 Q3	$5.96M	Buy	+44,397	New	+$6.37M	0.08%	231
2021 Q4	–	Sell	-35,336	Closed	-$3.77M	–	171
2021 Q3	$3.77M	Buy	35,336 +26,173	+286%	+$2.99M	0.05%	279
2021 Q2	$1.02M	Buy	9,163 +7,387	+416%	+$832K	0.02%	368
2021 Q1	$192K	Buy	+1,776	New	+$190K	﹤0.01%	444
2020 Q2	–	Sell	-92,257	Closed	-$8.12M	–	302
2020 Q1	$7.03M	Buy	92,257 +28,280	+44%	+$2.41M	0.25%	117
2019 Q4	$5.67M	Buy	+63,977	New	+$5.31M	0.12%	166
2019 Q3	–	Sell	-15,650	Closed	-$1.07M	–	300
2019 Q2	$1.14M	Buy	+15,650	New	+$1.23M	0.23%	85

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capula Management's ABBV Position: Q1 2026 in Review

Capula Management increased its AbbVie (ABBV) stake by 315% in Q1 2026, buying an estimated $1.08M and bringing the position to 6,392 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #308.

Capula Management first reported a position in ABBV in Q2 2019 and has held it in 18 quarters since. The position peaked at $7.03M in Q1 2020. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Capula Management held 6,392 shares of AbbVie worth $1.39M as of Q1 2026.
Capula Management bought 4,852 AbbVie shares in Q1 2026, an estimated $1.08M.
AbbVie made up 0.01% of Capula Management's portfolio in Q1 2026, its #308 holding.
Capula Management first reported a position in AbbVie in Q2 2019 and has held it in 18 quarters since.
Capula Management's AbbVie position peaked at $7.03M in Q1 2020.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.